Twelve UNC Lineberger Comprehensive Cancer Centers members were named to Clarivate’s 2022 Highly Cited Researchers list, which recognizes scientists who published papers that ranked in the top 1% of cited publications in their field during the past decade.
There is an urgent need for a vaccine with efficacy against SARS-CoV-2. We hypothesize that peptide vaccines containing epitope regions optimized for concurrent B cell, CD4+ T cell, and CD8+ T cell stimulation would drive both humoral and cellular immunity with high specificity, potentially avoiding undesired effects such as antibody-dependent enhancement (ADE)
UNC Lineberger’s Joel Parker, PhD, associate professor in the UNC School of Medicine Department of Genetics and director of cancer genetics for the UNC Lineberger Bioinformatics Core, presented the Haddow Lecture for The Institute of Cancer Research in London this year. In the lecture, he discussed novel computational methods to explore RNA sequencing data for cancer … Read more
The David and Lucile Packard Foundation announced the 2019 class of Packard Fellow for Science and Engineering, including Wesley Legant, PhD, in the biomedical engineering and pharmacology departments.
UNC Lineberger’s Benjamin G. Vincent, MD, and Christof Smith, PhD. Scientists at the University of North Carolina Lineberger Comprehensive Cancer Center have designed and validated a model for predicting what might make an effective cancer vaccine against a patient’s tumor. This finding could help overcome a significant obstacle in the development of personalized cancer … Read more
June 14, 2019 Wesley Legant, PhD, assistant professor in the departments of Pharmacology and Biomedical Engineering, earned this prestigious early career award for his work developing new fluorescence microscopes for rapid three-dimensional imaging. Wesley Legant, PhD, assistant professor in the Department of Pharmacology and the UNC/NCSU Joint Department of Biomedical Engineering, was named as a … Read more
Benjamin Vincent, MD, Assistant Professor in the School of Medicine (Hematology/Oncology) and his lab have performed a comprehensive genomics evaluation of the tumor immune microenvironment in The Cancer Genome Atlas dataset, discovering six immune subtypes of cancer. These and other findings are associated with survival and are being developed as biomarkers of immunotherapy response in multiple tumor … Read more